E Fund Management Co., Ltd. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 133 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q2 2023$244
+12.4%
8,523
-6.1%
0.02%
+18.8%
Q1 2023$217
-99.9%
9,073
-28.6%
0.02%
-5.9%
Q3 2022$188,000
-13.0%
12,713
-7.4%
0.02%
-15.0%
Q2 2022$216,000
-32.7%
13,735
+15.3%
0.02%
+81.8%
Q1 2022$321,00011,9100.01%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 253,300$6,829,0007.22%
Integral Health Asset Management, LLC 125,000$3,370,0000.88%
Green Alpha Advisors, LLC 23,013$620,0000.42%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 24,915$672,0000.41%
Nikko Asset Management Americas, Inc. 1,402,078$37,856,0000.28%
ARK Investment Management 2,383,840$64,268,0000.27%
FEDERATED HERMES, INC. 3,761,900$101,421,0000.23%
PDT Partners, LLC 49,500$1,335,0000.12%
NinePointTwo Capital LLC 12,417$334,0000.09%
Hennion & Walsh Asset Management, Inc. 59,385$1,601,0000.08%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders